Stay updated with breaking news from Toronto Memory Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The experimental drug lecanemab was able to slow down Alzheimer's in a large study. Many researchers think the drug will become the first to help large numbers of patients.
The experimental drug lecanemab was able to slow down Alzheimer's in a large study. Many researchers think the drug will become the first to help large numbers of patients.
Amplifying Atlanta
In a trial it slowed the disease’s progression and improved quality of life, yet there are risks.
:quality(70)/cloudfront-us-east-1.images.arcpublishing.com/tronc/YQ2H5ETZV5XQQPA63E72VT5WWY.jpg)
The latest Alzheimer’s drug, lecanemab. has stoked enthusiasm among some, but octors tempered their excitement after new data was released Tuesday.